HER2-Altered Non-Small Cell Lung Cancer — An Interview with Dr John V Heymach
About this episode
Dr. John Heymach discusses recent updates on treatment strategies for HER2-altered non-small cell lung cancer.
Dr John Heymach from The University of Texas MD Anderson Cancer Center in Houston discusses recent updates on available and novel treatment strategies for HER2-altered non-small cell lung cancer. CME information and select publications here .
People in this episode
Host: Dr. Neil Love
Guest: Dr John Heymach
Topics covered
- HER2-altered non-small cell lung cancer
- treatment strategies
- cancer research
- oncology
- medical education
Keywords
- HER2
- non-small cell lung cancer
- treatment strategies
- oncology
- cancer research
Mentioned in this episode
Organizations: The University of Texas MD Anderson Cancer Center, Lung Cancer Update
More episodes of Lung Cancer Update
- EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
- Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
- Extensive-Stage Small Cell Lung Cancer — Current Patterns of Care with First-Line and Maintenance Therapy
- Extensive-Stage Small Cell Lung Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy
- Lung Cancer — Proceedings from a Symposium Held in Partnership with the American Oncology Network
- Lung Cancer — 5-Minute Journal Club Issue 4 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Explore listener stats, chart rankings, contacts and more on the Lung Cancer Update podcast page.